The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers.
Rubio-Rivas M, Mora-Luján JM, Montero A, Aguilar García JA, Méndez Bailón M, Fernández Cruz A, Oriol I, Teigell-Muñoz FJ, Dendariena Borque B, De la Peña Fernández A, Fernández González R, Gil Sánchez R, Fernández Fernández J, Catalán M, Cortés-Rodríguez B, Mella Pérez C, Montero Rivas L, Suárez Fuentetaja R, Ternero Vega JE, Ena J, Martin-Urda Díez-Canseco A, Pérez García C, Varona JF, Casas-Rojo JM, Millán Núñez-Cortés J; SEMI-COVID-19 Network.
Rubio-Rivas M, et al. Among authors: de la pena fernandez a.
J Gen Intern Med. 2022 Jan;37(1):168-175. doi: 10.1007/s11606-021-07146-0. Epub 2021 Oct 18.
J Gen Intern Med. 2022.
PMID: 34664188
Free PMC article.